Can Venetoclax Plus R-CHOP Improve Outcomes in Aggressive DLBCL?

The results of the single-arm, multicenter, phase II part of the CAVALLI trial were presented at the 2018 ASH Annual Meeting& Exposition in San Diego.

Source: CancerNetwork - December 5, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news